Prosomnus Investor Relations Material
Latest events
Q4 2023
Prosomnus
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Prosomnus Inc
Access all reports
ProSomnus Inc is a medical technology company specializing in the development, manufacturing, and marketing of precision intraoral medical devices. These devices are designed to treat and manage obstructive sleep apnea (OSA), a condition that affects a significant portion of the global population. The company's innovative approach involves creating customized oral appliance therapy devices, offering a non-CPAP alternative for OSA treatment. ProSomnus sells its products through a direct sales force to a variety of healthcare providers, including sleep dentists, sleep physicians, primary care providers, and otolaryngologists, aiming to provide an effective solution for the management of sleep apnea. The company is headquartered in Pleasanton, California, and its shares are listed on the Nasdaq.
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
OSA
Country
πΊπΈ United States